PortfoliosLab logoPortfoliosLab logo
GLBE vs. TEVA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GLBE vs. TEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global-e Online Ltd. (GLBE) and Teva Pharmaceutical Industries Limited (TEVA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GLBE achieves a -18.21% return, which is significantly lower than TEVA's 6.57% return.


GLBE

1D
0.06%
1M
7.89%
YTD
-18.21%
6M
-15.86%
1Y
-7.05%
3Y*
-4.69%
5Y*
-4.40%
10Y*

TEVA

1D
-2.72%
1M
-6.91%
YTD
6.57%
6M
17.40%
1Y
87.17%
3Y*
65.55%
5Y*
25.39%
10Y*
-4.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GLBE vs. TEVA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GLBE
Global-e Online Ltd.
-18.21%-27.91%37.60%92.01%-67.44%148.59%
TEVA
Teva Pharmaceutical Industries Limited
6.57%41.61%111.11%14.47%13.86%-22.01%

Correlation

The correlation between GLBE and TEVA is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (All Time)
Calculated using the full available price history since May 13, 2021

0.22

Fundamentals

Market Cap

GLBE:

$5.59B

TEVA:

$39.21B

EPS

GLBE:

$0.67

TEVA:

$1.34

PE Ratio

GLBE:

48.01

TEVA:

24.87

PEG Ratio

GLBE:

0.01

TEVA:

0.19

PS Ratio

GLBE:

5.46

TEVA:

2.24

PB Ratio

GLBE:

6.14

TEVA:

4.76

Total Revenue (TTM)

GLBE:

$1.02B

TEVA:

$17.35B

Gross Profit (TTM)

GLBE:

$467.05M

TEVA:

$9.03B

EBITDA (TTM)

GLBE:

$146.46M

TEVA:

$3.05B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GLBE vs. TEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLBE
GLBE Risk / Return Rank: 3535
Overall Rank
GLBE Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
GLBE Sortino Ratio Rank: 3434
Sortino Ratio Rank
GLBE Omega Ratio Rank: 3434
Omega Ratio Rank
GLBE Calmar Ratio Rank: 3636
Calmar Ratio Rank
GLBE Martin Ratio Rank: 3333
Martin Ratio Rank

TEVA
TEVA Risk / Return Rank: 9090
Overall Rank
TEVA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
TEVA Sortino Ratio Rank: 9292
Sortino Ratio Rank
TEVA Omega Ratio Rank: 9191
Omega Ratio Rank
TEVA Calmar Ratio Rank: 8989
Calmar Ratio Rank
TEVA Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GLBE vs. TEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global-e Online Ltd. (GLBE) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GLBETEVADifference
Sharpe ratioReturn per unit of total volatility

-2.41

Sortino ratioReturn per unit of downside risk

-3.31

Omega ratioGain probability vs. loss probability

1.01

1.43

-0.42

Calmar ratioReturn relative to maximum drawdown

-0.21

4.02

-4.23

Martin ratioReturn relative to average drawdown

-0.49

10.94

-11.43

GLBE vs. TEVA - Sharpe Ratio Comparison

The current GLBE Sharpe Ratio is -0.15, which is lower than the TEVA Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of GLBE and TEVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GLBETEVADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.15

2.25

-2.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.06

0.59

-0.66

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.09

Sharpe Ratio (All Time)

Calculated using the full available price history

0.07

0.31

-0.25

Drawdowns

GLBE vs. TEVA - Drawdown Comparison

The maximum GLBE drawdown since its inception was -79.10%, smaller than the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for GLBE and TEVA.


Loading charts...

Drawdown Indicators


GLBETEVADifference

Max Drawdown

Largest peak-to-trough decline

-79.10%

-90.89%

+11.79%

Max Drawdown (1Y)

Largest decline over 1 year

-33.78%

-21.79%

-11.99%

Max Drawdown (3Y)

Largest decline over 3 years

-56.17%

-43.70%

-12.47%

Max Drawdown (5Y)

Largest decline over 5 years

-79.10%

-43.70%

-35.40%

Max Drawdown (10Y)

Largest decline over 10 years

-88.41%

Current Drawdown

Current decline from peak

-60.64%

-50.84%

-9.80%

Average Drawdown

Average peak-to-trough decline

-52.30%

-32.00%

-20.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.44%

8.00%

+6.44%

Volatility

GLBE vs. TEVA - Volatility Comparison

Global-e Online Ltd. (GLBE) has a higher volatility of 19.24% compared to Teva Pharmaceutical Industries Limited (TEVA) at 9.18%. This indicates that GLBE's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GLBETEVADifference

Volatility (1M)

Calculated over the trailing 1-month period

19.24%

9.18%

+10.06%

Volatility (6M)

Calculated over the trailing 6-month period

36.67%

23.54%

+13.13%

Volatility (1Y)

Calculated over the trailing 1-year period

46.68%

38.97%

+7.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.23%

42.94%

+25.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

68.21%

47.34%

+20.87%

Dividends

GLBE vs. TEVA - Dividend Comparison

Neither GLBE nor TEVA has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GLBE
Global-e Online Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.88%3.19%1.77%

Financials

GLBE vs. TEVA - Financials Comparison

This section allows you to compare key financial metrics between Global-e Online Ltd. and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
252.09M
3.98B
(GLBE) Total Revenue
(TEVA) Total Revenue
Values in USD except per share items

GLBE vs. TEVA - Profitability Comparison

The chart below illustrates the profitability comparison between Global-e Online Ltd. and Teva Pharmaceutical Industries Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

35.0%40.0%45.0%50.0%55.0%20222023202420252026
45.6%
49.5%
Portfolio components
GLBE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Global-e Online Ltd. reported a gross profit of 114.88M and revenue of 252.09M. Therefore, the gross margin over that period was 45.6%.

TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.

GLBE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Global-e Online Ltd. reported an operating income of 32.97M and revenue of 252.09M, resulting in an operating margin of 13.1%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.

GLBE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Global-e Online Ltd. reported a net income of 30.36M and revenue of 252.09M, resulting in a net margin of 12.0%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.


Frequently Asked Questions


GLBE and TEVA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GLBE has higher volatility (19.24%) compared to TEVA (9.18%). In terms of maximum drawdown, GLBE dropped -79.10% vs TEVA's -90.89%.

TEVA currently has the higher Sharpe Ratio (2.25 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GLBE and TEVA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer